- Tytuł:
- A PHASE 3 TRIAL OF ACALABRUTINIB, OBINUTUZUMAB AND VENETOCLAX COMPARED TO OBINUTUZUMAB AND VENETOCLAX IN PATIENTS WITH HIGH RISK CHRONIC LYMPHOCYTIC LEUKEMIA.
- Autorzy:
- Temat:
-
CHRONIC lymphocytic leukemia
CLINICAL trials
VENETOCLAX - Źródło:
- Hematological Oncology; Jun2023 Supplement 1, Vol. 41, p851-853, 3p
Czasopismo naukowe